2 курс / Гистология / ВОЗМОЖНОСТИ_ЖИДКОЙ_БИОПСИИ_В_СОВЕРШЕНСТВОВАНИИ_ПРОГНОЗА_ТЕЧЕНИЯ
.pdf131
156.Obermayr, E. Molecular characterization of circulating tumor cells in patients with ovarian cancer improves their prognostic significance - A study of the OVCAD consortium / E. Obermayr // Gynecologic Oncology. - 2013. - № 1 (128). C. 15–21.
157.Ombrato, L. The EMT Universe: Space between Cancer Cell Dissemination and Metastasis Initiation / L. Ombrato, I. Malanchi // Critical Reviews in Oncogenesis. - 2014. - V. 19 (5). - P. 349–361.
158.Ovarian cancer stem cells and macrophages reciprocally interact through the WNT pathway to promote pro-tumoral and malignant phenotypes in 3D engineered microenvironments / S. Raghavan, P. Mehta, Y. Xie et al. // Journal for ImmunoTherapy of Cancer. - 2019. - V. 7 (1). - P. 190.
159.Ovarian cancer stem cells promote tumour immune privilege and invasion via CCL5 and regulatory T cells / Y. You, Y. Li, M. Li et al. // Clinical and Experimental Immunology. - 2017. - V.191, № 1. - P. 60–73.
160.Ovarian hormones through Wntsignalling regulate the growth of human and mouse ovarian cancer initiating lesions / P.B. Nagendra, J. Goad, S. Nielsen et al. // Oncotarget. - 2016. - V. 7 (40). - P. 64836–64853.
161.Ovarian surface epithelium at the junction area contains a cancer-prone stem cell niche / A. Flesken-Nikitin, C.I. Hwang, C.Y. Cheng et al. // Nature. - 2013. - V. 495 (7440). - P. 241–245.
162.Overexpression of long non-coding RNA PVT1 in ovarian cancer cells promotes cisplatin resistance by regulating apoptotic pathways / E. Liu, Z. Liu, Y. Zhou et al. // International Journal of Clinical and Experimental Medicine. - 2015. - V. 8 (11). - P. 20565–20572.
163.Oxidative stress inhibits distant metastasis by human melanoma cells / E. Piskounova, M. Agathocleous, M.M. Murphy et al. // Nature. - 2015. - V. 527 (7577). - P.186-191.
164.Paget‟s “Seed and Soil” Theory of Cancer Metastasis: An Idea Whose Time has
Come / M. Akhtar, A. Haider, S. Rashid, ADMH. Al-Nabet // Advances in Anatomic
Pathology. - 2019. - V. 26 (1). - P. 69–74.
Рекомендовано к изучению сайтом МедУнивер - https://meduniver.com/
132
165.Pardini, B. MicroRNAs and Long Non-Coding RNAs and Their Hormone-Like Activities in Cancer / B. Pardini, G.Calin // Cancers. - 2019. - V. 11 (3). - P. 378.
166.Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary peritoneal malignancies: A Gynecologic Oncology Group study / K. Behbakht, M.W. Sill, K.M. Darcy et al. // Gynecologic Oncology. - 2011. - V. 123 (1). - P. 19–26.
167.Phenotypic Switch in Blood: Effects of Pro-Inflammatory Cytokines on Breast Cancer Cell Aggregation and Adhesion / Y. Geng, S. Chandrasekaran, J.W. Hsu et al. // PLoS ONE. - 2013. - V. 8 (1). - P. e54959.
168.Predictive Blood-Based Biomarkers in Patients with Epithelial Ovarian Cancer Treated with Carboplatin and Paclitaxel with or without Bevacizumab: Results from GOG-0218 / A. Alvarez Secord, K. Bell Burdett, K. Owzar et al. // Clinical Cancer Research. - 2020. - V. 26 (6). - P. 1288–1296.
169.Preoperative detection of peripherally circulating cancer cells and its prognostic significance in ovarian cancer / P.L. Judson, M.A. Geller, R.L. Bliss et al. // Gynecologic Oncology. - 2003. - V. 91 (2). - P. 389–394.
170.Prognostic analysis of invasive circulating tumor cells (iCTCs) in epithelial ovarian cancer / M.L. Pearl, Q. Zhao, J. Yang et al. // Gynecologic Oncology. - 2014. - V. 134 (3). - P. 581–590.
171.Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review / C. Yang, K. Zou, L. Zheng, B. Xiong // BMC Cancer. - 2017. - V. 17 (1). - P. 725.
172.Prognostic Relevance of Viable Circulating Tumor Cells Detected by EPISPOT in Metastatic Breast Cancer Patients / J.M. Ramirez, T. Fehm, M. Orsini et al. // Clinical Chemistry. - 2014. - V. 60 (1). - P. 214–221.
173.Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study / M. Arnold, M.J. Rutherford, A. Bardot et al. // The Lancet Oncology. - 2019. - V. 20 (11). - P. 1493-1505.
133
174.Prospective identification of tumorigenic breast cancer cells / M. Al-Hajj, M.S. Wicha, A. Benito-Hernandez et al. // Proceedings of the National Academy of Sciences.- 2003. - V. 100 (7). - P. 3983–3988.
175.Prospective Identification of Tumorigenic Prostate Cancer Stem Cells / A.T. Collins, P.A. Berry, C. Hyde et al. // Cancer Research. - 2005. - V. 65 (23). - P. 10946–
10951.
176.PVT1 dependence in cancer with MYC copy-number increase / Y.Y. Tseng, B.S. Moriarity, W. Gong et al. // Nature. - 2014. - V. 512 (7512). - P. 82–86.
177.Quantitative Proteomics Analysis Reveals Novel Insights into Mechanisms of Action of Long Noncoding RNA Hox Transcript Antisense Intergenic RNA (HOTAIR) in HeLa Cells / P. Zheng, Q. Xiong, Y. Wu et al. // Molecular & Cellular Proteomics. - 2015. - V. 14 (6). - P. 1447–1463.
178.Response rates to second-line platinum-based therapy in ovarian cancer patients challenge the clinical definition of platinum resistance / K. Lindemann, B. Gao, C. Mapagu et al. // Gynecologic. Oncology. - 2018. - V. 150 (2). - P. 239–246.
179.Retrospective Analysis Of Comparative Outcomes In Recurrent Platinum-Sensitive Ovarian Cancer Treated With Pegylated Liposomal Doxorubicin (Lipo-Dox) And Carboplatin Versus Paclitaxel And Carboplatin / C.S. Weng, C.C. Wu, T.C. Chen, et al. // Cancer Management and Research. - 2019. - V. 11. - P. 9899–9905.
180.Reymond, N. Crossing the endothelial barrier during metastasis / N. Reymond,
B.B. d‟Água A.J. Ridley // Nature Reviews Cancer. - 2013. - V. 13 (12). - P. 858–870.
181.RNA Biomarkers: Frontier of Precision Medicine for Cancer / X. Xi, T. Li, Y. Huang et al. // Non-Coding RNA. - 2017. - V. 3 (1). - P. 9.
182.Roque, R. Epithelial-mesenchymal interconversions in ovarian cancer: The levels and functions of E-cadherin in intraabdominal dissemination / R. Roque, F. Costa Sousa, M. Figueiredo-Dias // Oncology Reviews. - 2020. - V. 4 (2). - P.475
183.Saini, M.Circulating Tumor Cell-Neutrophil Tango along the Metastatic Process / M. Saini, B.M. Szczerba, N. Aceto // Cancer Research. - 2019. - V. 79 (24). - P. 6067–
6073.
Рекомендовано к изучению сайтом МедУнивер - https://meduniver.com/
134
184.Sarkar, S. Comparison of VEGF-A secretion from tumor cells under cellular stresses in conventional monolayer culture and microfluidic three-dimensional spheroid models / S. Sarkar, C.-C. Peng, Y.-C. Tung // PLOS ONE. - 2020. - V. 15 (11). - P. e0240833.
185.Scheel, C. Cancer stem cells and epithelial–mesenchymal transition: Concepts and molecular links / C. Scheel, R.A. Weinberg // Seminars in Cancer Biology. - 2012. - V.
22(5–6). -P. 396–403.
186.Self-seeding circulating tumor cells promote the proliferation and metastasis of human osteosarcoma by upregulating interleukin-8 / T. Liu, Q. Ma, Y. Zhang et al. // Cell Death & Disease. - 2019. - V. 10 (8). - P. 575.
187.Senescence-associated reprogramming promotes cancer stemness / M. Milanovic, D.N.Y. Fan, D. Belenki et al. // Nature. - 2018. - V. 553 (7686). - P. 96–100. 188.SenGupta, S. Parent The Recruitment of Neutrophils to the Tumor Microenvironment Is Regulated by Multiple Mediators / S. SenGupta, L.E. Hein, C.A. // Frontiers in Immunology. - 2021. - V. 12. - P. 734188.
189.Serum cytokines and CXCR2: potential tumour markers in ovarian neoplasms / D.C. Micheli, M.P. Jammal, A. Martins-Filho et al. // Biomarkers. - 2020. - V. 25 (6). - P. 474–482.
190.Serum IL-6 and IL-8 Correlate with Prognostic Factors in Ovarian Cancer /
M.M.M. Sanguinete, P.H. Oliveira, A. Martins-Filho et al. // Immunological
Investigations. - 2017. - V. 46 (7). - P. 677–688.
191.Shackleton, M. Normal stem cells and cancer stem cells: similar and different / M. Shackleton // Seminars in Cancer Biology. - 2010. - V. 20 (2). - P. 85–92.
192.Shih, I.-M.Ovarian Tumorigenesis / I.-M. Shih, R.J. Kurman // The American Journal of Pathology. - 2004. - V. 164 (5). - P. 1511–1518.
193.Shiwarski, D.J. To "Grow" or "Go": TMEM16A Expression as a Switch between Tumor Growth and Metastasis in SCCHN / D.J. Shiwarski // Clinical Cancer Research. - 2014. - V. 20 (17). - P. 4673–4688.
135
194.Short-Term Circulating Tumor Cell Dynamics in Mouse Xenograft Models and Implications for Liquid Biopsy / A.L. Williams, J.E. Fitzgerald, F. Ivich et al. // Frontiers in Oncology. - 2020. - V. 10. - P. 601085.
195.Silva, I.A. Aldehyde Dehydrogenase in Combination with CD133 Defines Angiogenic Ovarian Cancer Stem Cells That Portend Poor Patient Survival / I.A. Silva // Cancer Research. - 2011. - V. 71 (11). - P. 3991–4001.
196.Singh, S. Aldehyde dehydrogenases in cellular responses to oxidative/ electrophilicstress / S. Singh // Free Radical Biology and Medicine. - 2013. - V. 56. - P. 89–101.
197.Sipak-Szmigiel, O. Serum and peritoneal fluid concentrations of soluble human leukocyte antigen, tumor necrosis factor alpha and interleukin 10 in patients with selected ovarian pathologies / O. Sipak-Szmigiel // Journal of Ovarian Research. - 2017. - V.10 (1). - P. 25.
198.Small Extracellular Vesicles Released from Ovarian Cancer Spheroids in Response to Cisplatin Promote the Pro-Tumorigenic Activity of Mesenchymal Stem Cells / N.
Vera, S. Acuña-Gallardo, F. Grünenwald et al. // International Journal of Molecular
Sciences. - 2019. - V. 20 (20). - P. 4972.
199.Snail is critical for tumor growth and metastasis of ovarian carcinoma / H. Jin, Y. Yu, T. Zhang et al. // Int J Cancer. - 2010. - V. 126 (9). - P.2102-2111
200.Snail promotes ovarian cancer progression by recruiting myeloid-derived suppressor cells via CXCR2 ligand upregulation / M. Taki, K. Abiko, T. Baba et al. // Nature Communications. - 2018. - V. 9 (1). - P. 1685.
201.Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma: Cadherin Regulation in Ovarian and Breast CA / S. Elloul, M.B. Elstrand, J.M. Nesland et al. // Cancer. - 2005. - V. 103 (8). - P. 1631–1643.
202.Sole, C. The circulating transcriptome as a source of cancer liquid biopsy biomarkers / C. Sole // Seminars in Cancer Biology. - 2019. - V. 58. - P. 100–108.
Рекомендовано к изучению сайтом МедУнивер - https://meduniver.com/
136
203. Sosa, M.S. Mechanisms of disseminated cancer cell dormancy: an awakening field / M.S. Sosa, P. Bragado, J.A. Aguirre-Ghiso // Nat Rev Cancer. – 2014. – V. 14 (9). – P. 611-622.
204.Starodubov, V.I. The burden of disease in Russia from 1980 to 2016: a systematic analysis for the Global Burden of Disease Study 2016 / L.B Marczak, E.Varavikova, B. Bikbov // Lancet. 2018. - V. 392 (10153). - P. 1138–1146.
205.Stem and Progenitor-Like Cells Contribute to the Aggressive Behavior of Human Epithelial Ovarian Cancer / S.A. Bapat, A.M. Mali, C.B. Koppikar, N.K. Kurrey // Cancer Research. - 2005. - V. 65 (8). - P. 3025–3029.
206.Stem Cell Plasticity and Dormancy in the Development of Cancer Therapy Resistance / M.L. De Angelis, F. Francescangeli, F. La Torre, A. Zeuner // Frontiers in Oncology. - 2019. - №9. - P. 626.
207.Stem-like Human Breast Cancer Cells Initiate Vasculogenic Mimicry on Matrigel /
Y. Izawa, K. Kashii-Magaribuchi, K. Yoshida et al. // Acta Histochemica et
Cytochemica. - 2018. - V. 51 (6). - P. 173–183.
208.Stewart, J.M. Phenotypic heterogeneity and instability of human ovarian tumorinitiating cells // Proceedings of the National Academy of Sciences. - 2011. - V. 108 (16). - P. 6468–6473.
209.Sub-Sets of Cancer Stem Cells Differ Intrinsically in Their Patterns of Oxygen Metabolism / L. Gammon, A. Biddle, H.K. Heywood et al. // PLoS ONE. - 2013. - V. 8
(4). - P. e62493.
210.Sun, Y.-F. Circulating Tumor Cells from Different Vascular Sites Exhibit Spatial Heterogeneity in Epithelial and Mesenchymal Composition and Distinct Clinical Significance in Hepatocellular Carcinoma / Y.F. Sun, W. Guo, Y. Xu et al. // Clinical Cancer Research. - 2018. - V. 24 (3). - P. 547–559.
211.Surface markers of cancer stem-like cells of ovarian cancer and their clinical relevance / A. Klemba, J.K. Purzycka-Olewiecka, G. Wcisło et al. // WspółczesnaOnkologia. - 2018. - № 1. - P. 48–55.
137
212. Targeting c-MYC in Platinum-Resistant Ovarian Cancer / J.M. Reyes-González,
G.N. Armaiz-Peña, L.S. Mangala et al. // Molecular Cancer Therapeutics. - 2015. - V. 14 (10). - P. 2260–2269.
213.Tassan, J.-P. Asymmetric Cell Division in Development, Differentiation and Cancer / editors J.-P. Tassan, J.Z. Kubiak // Results and Problems in Cell Differentiation book series (RESULTS, vol. 61). Cham: Springer International
Publishing : Imprint: Springer, 2017. - 421 p.
214.Teeuwssen, M. WntSignaling in OvarianCancerStemness, EMT, and TherapyResistance/ M. Teeuwssen, R. Fodde // Journal of Clinical Medicine. - 2019. - V. 8 (10). - P. 1658.
215.TGF-β Family Signaling Pathways in Cellular Dormancy / C. Prunier, D. Baker, P. Ten Dijke, L. Ritsma // Trends in Cancer. - 2019. - V. 5 (1). - P. 66–78.
216.TGFβ1 in fibroblasts-derived exosomes promotes epithelial-mesenchymal transition of ovarian cancer cells / W. Li, X. Zhang, J. Wang et al. // Oncotarget. - 2017. - V. 8 (56). - P. 96035–96047.
217.Thakur, B. Cisplatin triggers cancer stem cell enrichment in platinum-resistant cells through NF-κB-TNFα-PIK3CA loop / B. Thakur, P. Ray // Journal of Experimental & Clinical Cancer Research. - 2017. - V. 36 (1). - P. 164.
218.The added value of circulating tumor cells examination in ovarian cancer staging /
K. Kolostova, R. Matkowski, M. Jędryka et al. // American Journal of Cancer Research.
- 2015. - V. 5 (11). - P. 3363–3375.
219.The cadherin switch in ovarian high-grade serous carcinoma is associated with disease progression / L. Quattrocchi, A.R. Green, S. Martin et al. // VirchowsArchiv. - 2011. - V. 459 (10. - P. 21-29.
220.The Cancer Genome Atlas Research Network Integrated genomic analyses of ovarian carcinoma / D. Bell, A. Berchuck, M. Birrer // Nature. - 2011. - V. 474 (7353). - P. 609–615.
221.The Cancer Stem Cell Niche in Ovarian Cancer and Its Impact on Immune Surveillance / S. Jain, S.L. Annett, M.P. Morgan, T. Robson // International Journal of Molecular Sciences. - 2021. - V. 22 (8). - P. 4091.
Рекомендовано к изучению сайтом МедУнивер - https://meduniver.com/
138
222.The E-Cadherin and N-Cadherin Switch in Epithelial-to-Mesenchymal Transition: Signaling, Therapeutic Implications, and Challenges / C.Y. Loh, J.Y. Chai, T.F. Tang et al. // Cells. 2019. - V. 8 (10). - P. 1118.
223.The epigenetic/noncoding origin of tumor dormancy / F. Crea, N.R. Nur Saidy, C.C. Collins, Y. Wang // Trends in Molecular Medicine. - 2015. - V. 21 (4). - P. 206–
211.
224.The impact of second to sixth line therapy on survival of relapsed ovarian cancer after primary taxane/platinum-based therapy /L.C. Hanker, S. Loibl, N. Burchardi et al. // Annals of Oncology. - 2012. - V. 23 (10). - P. 2605–2612.
225.The Lancet Oncology Cancer detection: the quest for a single liquid biopsy for all // Lancet Oncology. - 2020. - V. 21 (60. - P. 733.
226.The Long Noncoding RNA HOTAIR Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma Cells via downregualtion of p21WAF1/CIP1 Expression / Z. Liu, M. Sun, K. Lu et al. // PLoS ONE. - 2013. - V. 8 (10). - P. e77293.
227.The Long-Term Prognostic Significance of Circulating Tumor Cells in Ovarian Cancer - A Study of the OVCAD Consortium / E. Obermayr, D.C. Castillo-Tong, D. Pils et al. // Cancers. 2021. - V. 13 (11). - P. 2613.
228.The Predictive Value of Circulating Tumor Cells in Ovarian Cancer: A Meta Analysis / L. Zeng, X. Liang, Q. Liu, Z. Yang // International Journal of Gynecologic Cancer. - 2017. - V. 27 (6). - P. 1109–1117.
229.The prognostic impact of cancer stem-like cell biomarker aldehyde dehydrogenase-
1(ALDH1) in ovarian cancer: A meta-analysis / I. Ruscito, S. Darb-Esfahani, H. Kulbe et al. // Gynecologic Oncology. - 2018. - V. 150 (1). - P. 151–157.
230.The reactome pathway knowledgebase / B. Jassal, L. Matthews, G. Viteri et al. // Nucleic Acids Res. - 2020 . - V. 48 (D1). - P. D498-D503.
231.The role of surgery in advanced epithelial ovarian cancer / M. Martín-Cameán, E.
Delgado-Sánchez, A. Piñera et al. // Ecancer medical science. - 2016. - V.10. - P. 666. 232. The T cell differentiation landscape is shaped by tumour mutations in lung cancer / E. Ghorani, J.L. Reading, J.Y. Henry et al. // Nature Cancer. - 2020. - V. 1 (5). - P. 546– 561.
139
233.Thiery J.P. Epithelial-Mesenchymal Transitions in Development and Disease / J.P. Thiery, H. Acloque, R.Y. Huang, M.A. Nieto // Cell. - 2009. - V. 139 (5). - P. 871–890. 234. Tomasetti, C. Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions / C. Tomasetti, B. Vogelstein // Science.
– 2015. – V. 347 (6217). P. 78-81.
235.Transient depletion of p53 followed by transduction of c-Myc and K-Ras converts ovarian stem-like cells into tumor-initiating cells / T. Motohara, S. Masuko, T. Ishimoto et al. // Carcinogenesis. - 2011. - V. 32 (11). - P. 1597–1606.
236.TRPM2 modulates neutrophil attraction to murine tumor cells by regulating CXCL2 expression / M. Gershkovitz, T. Fainsod-Levi, T. Zelter et al. // Cancer Immunology, Immunotherapy. - 2019. - V. 68 (1). - P. 33–43.
237.Tumor microenvironment: The culprit for ovarian cancer metastasis? / Z. Luo, Q. Wang, W.B. Lau et al. // Cancer Lett. 2016 Jul 28;377(2):174-82.
238.Tumor-associated macrophages drive spheroid formation during early transcoelomic metastasis of ovarian cancer / M. Yin, X. Li, S. Tan et al. // Journal of Clinical Investigation. - 2016. - V. 126 (11). - P. 4157–4173.
239.VEGFA activates an epigenetic pathway upregulating ovarian cancer initiating
cells / K. Jang, M. Kim, C.A. Gilbert et al. // EMBO Molecular Medicine. - 2017. - V. 9
(3). - P. 304–318.
240.Who are the long-term survivors of high grade serous ovarian cancer? / C. Hoppenot, M.A. Eckert, S.M. Tienda, E. Lengyel // Gynecologic Oncology. - 2018. - V.
148(1). - P. 204–212.
241.WNT signaling inducing activity in ascites predicts poor outcome in ovarian
cancer / A. Kotrbová, P. Ovesná, T. Gybel' et al. // Theranostics. - 2020. - V. 10 (2). - P.
537–552.
Рекомендовано к изучению сайтом МедУнивер - https://meduniver.com/